AllianceBernstein
CLPT icon

AllianceBernstein’s ClearPoint Neuro CLPT Stock Holding History

AllianceBernstein’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$216K Hold
15,800
– – ﹤0.01% 3019
2025
Q4 		$216K Hold
15,800
– – ﹤0.01% 3040
2025
Q3 		$344K Buy
+15,800
New +$186K ﹤0.01% 2875

Other funds holding CLPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

AllianceBernstein's CLPT Position: Q1 2026 in Review

AllianceBernstein held its ClearPoint Neuro (CLPT) position steady in Q1 2026 at 15,800 shares worth $216K. The position accounts for ﹤0.01% of the portfolio, ranked #3019.

AllianceBernstein first reported a position in CLPT in Q3 2025 and has held it in 3 quarters since. The position peaked at $344K in Q3 2025. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

  • AllianceBernstein held 15,800 shares of ClearPoint Neuro worth $216K as of Q1 2026.
  • AllianceBernstein left its ClearPoint Neuro share count unchanged in Q1 2026.
  • ClearPoint Neuro made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #3019 holding.
  • AllianceBernstein first reported a position in ClearPoint Neuro in Q3 2025 and has held it in 3 quarters since.
  • AllianceBernstein's ClearPoint Neuro position peaked at $344K in Q3 2025.
  • 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.